Leona E. Ling

Person

Winchester, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for predicting response to treatment
- Patent number 12,163,951
- Issue date Dec 10, 2024
- Momenta Pharmaceuticals, Inc.
- Ishan Capila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods related to engineered Fc constructs
- Patent number 12,071,482
- Issue date Aug 27, 2024
- Momenta Pharmaceuticals, Inc.
- Carlos J. Bosques
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,773,168
- Issue date Oct 3, 2023
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,732,047
- Issue date Aug 22, 2023
- Momenta Pharmaceuticals, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sialylated glycoproteins
- Patent number 11,661,456
- Issue date May 30, 2023
- Momenta Pharmaceuticals, Inc.
- Birgit C. Schultes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for predicting response to treatment
- Patent number 11,639,923
- Issue date May 2, 2023
- Momenta Pharmaceuticals, Inc.
- Ishan Capila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the treatment of neurodegeneration
- Patent number 11,352,415
- Issue date Jun 7, 2022
- Momenta Pharmaceuticals, Inc.
- Thomas E. Prod'Homme
- G01 - MEASURING TESTING
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,345,751
- Issue date May 31, 2022
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods related to engineered Fc constructs
- Patent number 11,124,573
- Issue date Sep 21, 2021
- Janssen Biotech, Inc.
- Carlos J. Bosques
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 10,676,526
- Issue date Jun 9, 2020
- Momenta Pharmaceuticals, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the treatment of neurodegeneration
- Patent number 10,464,996
- Issue date Nov 5, 2019
- Momenta Pharmaceuticals, Inc.
- Thomas E. Prod'Homme
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods related to engineered Fc constructs
- Patent number 10,239,944
- Issue date Mar 26, 2019
- Momenta Pharmaceuticals, Inc.
- Carlos J. Bosques
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20240158508
- Publication date May 16, 2024
- MOMENTA PHARMACEUTICALS, INC.
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FCRN ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240158509
- Publication date May 16, 2024
- MOMENTA PHARMACEUTICALS, INC.
- Leona E. Ling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sialylated Glycoproteins
- Publication number 20240052040
- Publication date Feb 15, 2024
- MOMENTA PHARMACEUTICALS, INC.
- Birgit C. Schultes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREDICTING RESPONSE TO TREATMENT
- Publication number 20230221302
- Publication date Jul 13, 2023
- MOMENTA PHARMACEUTICALS, INC.
- Ishan Capila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20230049725
- Publication date Feb 16, 2023
- MOMENTA PHARMACEUTICALS, INC.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For The Treatment Of Neurodegeneration
- Publication number 20220267413
- Publication date Aug 25, 2022
- MOMENTA PHARMACEUTICALS, INC.
- Thomas E. Prod`Homme
- G01 - MEASURING TESTING
Information Patent Application
METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
- Publication number 20220153833
- Publication date May 19, 2022
- Momenta Pharmaceuticals, Inc.
- Carlos J. BOSQUES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FCRN ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220144946
- Publication date May 12, 2022
- JANSSEN BIOTECH, INC.
- Sindhu Ramchandran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20220064290
- Publication date Mar 3, 2022
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
- Publication number 20220033499
- Publication date Feb 3, 2022
- JANSSEN BIOTECH, INC.
- Carlos J. Bosques
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20210238275
- Publication date Aug 5, 2021
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for the Diagnosis and Treatment of Kawasak...
- Publication number 20210116462
- Publication date Apr 22, 2021
- Momenta Pharmaceuticals, Inc.
- Dorota A. BULIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20200299382
- Publication date Sep 24, 2020
- Momenta Pharmaceuticals, Inc.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREDICTING RESPONSE TO TREATMENT
- Publication number 20200256851
- Publication date Aug 13, 2020
- Momenta Pharmaceuticals, Inc.
- Ishan Capila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sialylated Glycoproteins
- Publication number 20200087402
- Publication date Mar 19, 2020
- Momenta Pharmaceuticals, Inc.
- Birgit C. Schultes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For The Treatment Of Neurodegeneration
- Publication number 20200055921
- Publication date Feb 20, 2020
- Momenta Pharmaceuticals, Inc.
- Thomas E. Prod`Homme
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
- Publication number 20190225688
- Publication date Jul 25, 2019
- Momenta Pharmaceuticals, Inc.
- Carlos J. Bosques
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic and Diagnostic Methods for Autoimmune Diseases and/or I...
- Publication number 20190048417
- Publication date Feb 14, 2019
- Momenta Pharmaceuticals, Inc.
- Nathaniel Washburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sialylated Glycoproteins
- Publication number 20180327498
- Publication date Nov 15, 2018
- Momenta Pharmaceuticals, Inc.
- Birgit C. Schultes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FCRN ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20180016334
- Publication date Jan 18, 2018
- Momenta Pharmaceuticals, Inc.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
- Publication number 20170066826
- Publication date Mar 9, 2017
- Momenta Pharmaceuticals, Inc.
- Carlos J. BOSQUES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF KAWASAK...
- Publication number 20170052200
- Publication date Feb 23, 2017
- Momenta Pharmaceuticals, Inc.
- Dorota A. BULIK
- G01 - MEASURING TESTING
Information Patent Application
SIALYLATED GLYCOPROTEINS
- Publication number 20160257754
- Publication date Sep 8, 2016
- Momenta Pharmaceuticals Inc.
- Birgit C. SCHULTES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
- Publication number 20160229913
- Publication date Aug 11, 2016
- Momenta Pharmaceuticals, Inc.
- Carlos J. BOSQUES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE TREATMENT OF NEURODEGENERATION
- Publication number 20160090409
- Publication date Mar 31, 2016
- Momenta Pharmaceuticals, Inc.
- Thomas E. PROD'HOMME
- G01 - MEASURING TESTING
Information Patent Application
Angiogenesis-modulating compositions and uses
- Publication number 20100183560
- Publication date Jul 22, 2010
- Curis, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrazoles and methods of making and using the same
- Publication number 20060264440
- Publication date Nov 23, 2006
- Biogen Idec MA Inc.
- Wen-Cherng Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Angiogenesis-modulating compositions and uses
- Publication number 20050054568
- Publication date Mar 10, 2005
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Angiogenesis-modulating compositions and uses
- Publication number 20030022819
- Publication date Jan 30, 2003
- Leona E. Ling
- C07 - ORGANIC CHEMISTRY

Leona E. Ling

Person

Patents Grantslast 30 patents

Methods for predicting response to treatment

Compositions and methods related to engineered Fc constructs

FcRn antibodies and methods of use thereof

FcRn antibodies and methods of use thereof

Sialylated glycoproteins

Methods for predicting response to treatment

Methods for the treatment of neurodegeneration

FcRn antibodies and methods of use thereof

Compositions and methods related to engineered Fc constructs

FcRn antibodies and methods of use thereof

Methods for the treatment of neurodegeneration

Compositions and methods related to engineered Fc constructs

Patents Applicationslast 30 patents

FcRn Antibodies and Methods of Use Thereof

FCRN ANTIBODIES AND METHODS OF USE THEREOF

Sialylated Glycoproteins

METHODS FOR PREDICTING RESPONSE TO TREATMENT

FcRn Antibodies and Methods of Use Thereof

Methods For The Treatment Of Neurodegeneration

METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

FCRN ANTIBODIES AND METHODS OF USE THEREOF

FcRn Antibodies and Methods of Use Thereof

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

FcRn Antibodies and Methods of Use Thereof

Methods and Compositions for the Diagnosis and Treatment of Kawasak...

FcRn Antibodies and Methods of Use Thereof

METHODS FOR PREDICTING RESPONSE TO TREATMENT

Sialylated Glycoproteins

Methods For The Treatment Of Neurodegeneration

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

Therapeutic and Diagnostic Methods for Autoimmune Diseases and/or I...

Sialylated Glycoproteins

FCRN ANTIBODIES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF KAWASAK...

SIALYLATED GLYCOPROTEINS

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

METHODS FOR THE TREATMENT OF NEURODEGENERATION

Angiogenesis-modulating compositions and uses

Pyrazoles and methods of making and using the same

Angiogenesis-modulating compositions and uses

Angiogenesis-modulating compositions and uses